FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Merck Sharp & Dohme Janumet Recall

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, package…

MERCK SHARP & DOHME CORP · Whitehouse Station, NJ

Risk level
Class II
Reported by FDA
Apr 13, 2022
Recall ID
D-0746-2022
Check your lot numberHow we source this data

Summary

Merck Sharp & Dohme recalled Janumet starting Mar 31, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0746-2022 on Apr 13, 2022. Reason: Presence of foreign substance: Presence of stainless steel particulates in tablets. Status: Terminated.

Why it was recalled

Presence of foreign substance: Presence of stainless steel particulates in tablets.

Product description

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)

Lot numbers, UPCs & expiration codes

Lot: U015824, Exp. 09/22.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0746-2022
Classification
Class II
Status
Terminated
Recall initiated
Mar 31, 2022
FDA report date
Apr 13, 2022
Quantity
3600 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
MERCK SHARP & DOHME CORP

Original FDA data

Every field from FDA enforcement report D-0746-2022, exactly as published.

Show all FDA fields
City
Whitehouse Station
State
NJ
Status
Terminated
Country
United States
Event ID
89893
Address
1 Merck Dr
Code information
Lot: U015824, Exp. 09/22.
Postal code
08889-3400
Report date
Apr 13, 2022
Product type
Drugs
Recall number
D-0746-2022
Classification
Class II
Recalling firm
MERCK SHARP & DOHME CORP
Product quantity
3600 cartons
Termination date
Aug 15, 2023
Reason for recall
Presence of foreign substance: Presence of stainless steel particulates in tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 31, 2022
Initial firm notification
Letter
Center classification date
Apr 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0746-2022, published Apr 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls